Ultragenyx

MEPSEVII

  1. Home
  2.  / 
  3. J Code
  4.  / MEPSEVII – J3397

Manufacturer:

Ultragenyx

Name:

MEPSEVII

HCPCS Code Descriptor:

Injection, vestronidase alfa-vjbk, 1 mg

Category:

J Code

HCPCS:

J3397

NDC(s):

69794-0001-01

Primary Type:

Enzyme Replacement Therapy

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

MEPSEVII is an Enzyme Replacement Therapy drug manufactured by Ultragenyx and administered via the Intravenous route of administration. The J Code: J3397 is aligned to the drug MEPSEVII.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Inj., vestronidase alfa-vjbk

Billing and Coding Guide:

https://www.mepsevii.com/hcp/patient-services-reimbursement/billing-and-coding/

Patient Assistance:

https://www.ultracaresupport.com/patient-services/